Amgen (NQ:AMGN)

426.11 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

73 74 Next >

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Three Healthcare Buys That Wall Street Loves ↗

November 11, 2025

These three healthcare stocks are outperforming most of the sector.

Via The Motley Fool

The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call

November 11, 2025

Amgen’s third quarter results were well received by the market, reflecting robust volume-driven growth across its diversified portfolio. Management credited rising demand for key medicines—including...

Via StockStory

Topics Earnings

Amgen Stock Extends Rally After-Hours As CEO Hypes New Cholesterol Drug Data On Jim Cramer’s Show ↗

November 10, 2025

Via Stocktwits

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

November 10, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its peers.

Via StockStory

Topics Artificial Intelligence

2 Cash-Producing Stocks to Research Further and 1 We Find Risky

November 09, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Topics Credit Cards

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60% ↗

November 08, 2025

Merck said Saturday its new pill — a possible rival to Regeneron and Amgen — lowered high cholesterol by almost 60%.

Via Investor's Business Daily

Market Reels from Volatility and Mixed Signals: A Deep Dive into Investor Unease

November 08, 2025

The past week, from November 1st to November 8th, 2025, has witnessed a significant shift in global market sentiment, moving decisively towards a "risk-off" stance. Investors are grappling with...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Amgen Stock: New All-Time Highs Ahead After Earnings Beat ↗

November 07, 2025

Via MarketBeat

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025....

Via MarketMinute

Topics Intellectual Property

Wall Street Shakes Off Jitters as AMD and McDonald’s Impress ↗

November 06, 2025

Stronger-than-expected job data and upbeat corporate earnings pushed U.S. markets higher, despite recent warnings of an imminent correction.

Via Chartmill

3 Large-Cap Stocks to Consider Right Now

November 05, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Topics Supply Chain

Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars

November 05, 2025

The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo...

Via MarketMinute

Topics Economy

Why Amgen Stock Was Crushing It on Wednesday ↗

November 05, 2025

Its latest quarterly results were solid, thanks to strong sales of its top products.

Via The Motley Fool

Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗

November 05, 2025

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing...

Via Benzinga

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

November 05, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance

November 05, 2025

Biotech company Amgen (NASDAQ:AMGN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 12.4% year on year to $9.56 billion. The company’s full-year revenue guidance of...

Via StockStory

These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Amgen (NASDAQ:AMGN) Delivers Strong Q3 Numbers

November 04, 2025

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.4% year on year to $9.56 billion. The company’s full-year revenue guidance of $36.2 billion at...

Via StockStory

Amgen Crushes Third-Quarter Expectations On The Back Of Two Blockbusters ↗

November 04, 2025

The biotech giant also raised its sales and adjusted earnings outlook for the year.

Via Investor's Business Daily

Topics Earnings

Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday? ↗

November 04, 2025

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...

Via Benzinga

Amgen Earnings: What To Look For From AMGN

November 02, 2025

Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings this Tuesday after market close. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

You Won't Believe What Elon Musk Just Said About Quantum Computing (Spoiler Alert: It's Good News) ↗

November 02, 2025

Elon Musk had some encouraging thoughts following Alphabet's latest quantum breakthrough.

Via The Motley Fool

Topics Artificial Intelligence

Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout

October 31, 2025

Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...

Via MarketMinute

Topics Intellectual Property

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks ↗

October 31, 2025

Via MarketBeat

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.